"HIV and Cancer in Kampala, Uganda."

According to an abstract submitted by the authors to the 2nd National AIDS Malignancy Conference, held April 6-8, 1998, in Bethesda, Maryland, "In a study of the relationship between HIV and cancer, in Kampala, Uganda, subjects with incident cancer are recruited from the main hospitals and submitted to an HIV test. Between August 1994 and October 1997, 1749 individuals with cancer were tested for HIV. The HIV seroprevalence in all cancers excluding Kaposi's sarcoma, non-Hodgkin's lymphoma and squamous cell carcinoma of the conjunctive (which are already known to be HIV-associated) was 16%, in line with independent seroprevalence data from Kampala. These were used as a comparison group...

Want to see the full article?

• Purchase this article for only $3.00